NCT04919629
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +29 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Clinical trial condition
Primary Peritoneal Clear Cell Adenocarcinoma
Explore clinical trials studying Primary Peritoneal Clear Cell Adenocarcinoma. Study availability and eligibility vary by location and protocol.
6 public trials
3 recruiting studies
Primary Peritoneal Clear Cell Adenocarcinoma trial results
NCT04575935
- Conditions
- Adnexal Diseases, Advanced Ovarian Carcinoma, Endocrine Gland Neoplasms, +39 more
- Locations
-
- University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
- Cleveland Clinic Foundation - Florida Weston, Florida, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT06639074
- Conditions
- Advanced Fallopian Tube Carcinoma, Advanced Fallopian Tube High Grade Serous Adenocarcinoma, Advanced Ovarian Carcinoma, +15 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT00951496
- Conditions
- Adnexal Diseases, Brenner Tumor, Endocrine System Diseases, +55 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
NCT02020707
- Conditions
- Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma, +45 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Active, Not Recruiting
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
NCT00565851
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, +51 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
Related conditions
- Fallopian Tube Clear Cell Adenocarcinoma (6)
- Fallopian Tube Endometrioid Adenocarcinoma (5)
- Ovarian Clear Cell Adenocarcinoma (5)
- Ovarian Endometrioid Adenocarcinoma (5)
- Ovarian Serous Adenocarcinoma (5)
- Primary Peritoneal Endometrioid Adenocarcinoma (5)
- Primary Peritoneal Serous Adenocarcinoma (5)
- Adnexal Diseases (4)